v3.26.3
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Disaggregation of Revenue [Line Items]          
Net sales $ 6,520 $ 6,057 $ 19,129 $ 17,945  
Contract liabilities 960   960   $ 1,024
Orthopaedic Instruments          
Disaggregation of Revenue [Line Items]          
Net sales 535 492 1,547 1,477  
Other Orthopedics          
Disaggregation of Revenue [Line Items]          
Net sales 219 159 570 440  
Neuro Cranial Instruments          
Disaggregation of Revenue [Line Items]          
Net sales 670 637 1,957 1,816  
Enabling Technologies          
Disaggregation of Revenue [Line Items]          
Net sales $ 28 $ 45 $ 82 $ 108  
Customer Lease Agreements | Revenue Benchmark | Product Concentration Risk          
Disaggregation of Revenue [Line Items]          
Concentration risk (as a percent) 4.00% 4.00% 4.00% 4.00%